Hadron therapy sales will grow through 2036, led by proton beam therapy at 38.4% of the beam types segment in 2026. Pediatric cancer leads the application segment with a 21.6% share. The market is projected to reach USD 1.7 billion in 2026 and USD 2.6 billion by 2036.